智通财经APP讯，科华生物(002022.SZ)发布公告，近日，公司控股子公司苏州天隆生物科技有限公司收到国家药品监督管理局颁发的医疗器械注册证(体外诊断试剂)。涉及药品：“丙型肝炎病毒(HCV)核酸检测试剂盒(PCR-荧光法)”。该产品用于定量检测人血清或血浆样本中的丙型肝炎病毒核酸(RNA)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.